ent-3-oxokaurane-16alpha,17-diol

ID: ALA4475260

PubChem CID: 155537489

Max Phase: Preclinical

Molecular Formula: C20H32O3

Molecular Weight: 320.47

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC1(C)C(=O)CC[C@]2(C)[C@@H]1CC[C@@]13C[C@H](CC[C@H]12)[C@@](O)(CO)C3

Standard InChI:  InChI=1S/C20H32O3/c1-17(2)14-6-9-19-10-13(20(23,11-19)12-21)4-5-15(19)18(14,3)8-7-16(17)22/h13-15,21,23H,4-12H2,1-3H3/t13-,14+,15-,18+,19-,20-/m0/s1

Standard InChI Key:  MPDUJZZNNBJFAB-OEVJXTTPSA-N

Molfile:  

 
     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
    6.2346  -25.8619    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0641  -28.6323    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6556  -27.9173    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2424  -28.6296    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9448  -26.6831    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9448  -27.5088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6593  -26.2662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3695  -26.6831    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3706  -27.5088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0841  -27.9183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7969  -27.5069    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0819  -26.2671    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7997  -26.6860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5139  -26.2779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5213  -25.4493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8035  -25.0304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0827  -25.4401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2285  -27.9227    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3662  -28.3302    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    3.3620  -25.8575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0770  -27.0917    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    5.5068  -27.0960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8176  -25.2745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9452  -26.2746    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.6009  -24.4742    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3026  -24.6489    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
  3  2  1  0
  3  4  1  0
  5  6  1  0
  5  7  1  0
  6  3  1  0
  3  9  1  0
  8  7  1  0
  8  9  1  0
  8 12  1  0
  9 10  1  0
 10 11  1  0
 11 13  1  0
 12 13  1  0
 12 17  1  0
 13 14  1  0
 15 14  1  0
 15 16  1  0
 16 17  1  0
  6 18  2  0
  9 19  1  1
  8 20  1  6
 12 21  1  1
 15  1  1  0
 13 22  1  1
  1 22  1  0
  1 23  1  0
  1 24  1  6
 23 25  1  0
 15 26  1  1
M  END

Alternative Forms

  1. Parent:

    ALA4475260

    ---

Associated Targets(non-human)

BV-2 (3710 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 320.47Molecular Weight (Monoisotopic): 320.2351AlogP: 3.32#Rotatable Bonds: 1
Polar Surface Area: 57.53Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 13.69CX Basic pKa: CX LogP: 2.93CX LogD: 2.93
Aromatic Rings: Heavy Atoms: 23QED Weighted: 0.78Np Likeness Score: 3.64

References

1. Liang Y, An L, Shi Z, Zhang X, Xie C, Tuerhong M, Song Z, Ohizumi Y, Lee D, Shuai L, Xu J, Guo Y..  (2019)  Bioactive Diterpenoids from the Stems of Euphorbia antiquorum.,  82  (6): [PMID:31180680] [10.1021/acs.jnatprod.9b00134]

Source